Physician profile
Daniel Hawkins
NPI 1750736922
$5,642.71
in general payments reported to CMS, 2019-2025
10 companies · $636 in 2025
The $636 reported for 2025 was more than what 77% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2021: $1,835 · 2022: $84.24 · 2023: $519 · 2024: $2,456 · 2025: $636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,330 · Travel and Lodging: $1,281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,329.89 |
| Travel and Lodging | $1,280.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,671.69 | 2019-2025 | Na, Smartlock, Vsp System, Vsp Cranial |
| Medical Device Business Services, INC. | $1,404.76 | 2021 | |
| Depuy Synthes Sales INC. | $694.14 | 2021-2025 | Trumatch, Matrixmidface, Matrixmandible |
| Axogen | $441.60 | 2022-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Ha+ Nerve Protector |
| Biocircuit Technologies INC | $211.13 | 2025 | Nerve Tape |
| Kls-Martin L.P. | $80.08 | 2024 | |
| Geistlich Pharma, North America, INC. | $55.42 | 2021 | |
| Dentsply Sirona INC | $31.11 | 2023 | Astra Tech Implant System |
| Inspire Medical Systems, INC. | $27.32 | 2023 | Inspire |
| Integra Lifesciences Corporation | $25.46 | 2023 | Tenoglide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hawkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.